KIF21A and cancer: The analysis of the scRNA-seq data revealed that KIF21A and PIGH predominantly localize to NK cells, CD4+ T cells, and CD8+ T cells, and decreased expression of these genes may reduce the activation of NK cells and reduce the number of NK cells in patients with T1DM, increasing the risk of cancer onset (6, 57).